Loading...

DexCom, Inc.

DXCM•NASDAQ
Healthcare
Medical - Devices
$61.57
$-1.13(-1.80%)
U.S. Market opens in 30h 28m

DexCom, Inc. (DXCM) Stock Overview

Explore DexCom, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap23.8B
P/E Ratio28.37
EPS (TTM)$2.09
ROE0.32%
Fundamental Analysis

AI Price Forecasts

1 Month$78.61
3 Months$75.74
1 Year Target$62.27

DXCM Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of DexCom, Inc. (DXCM) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 39.94, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $62.27.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 28.37 and a market capitalization of 23.8B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-1.80%
5-Day Change
-1.38%
1-Month Change
-7.55%
3-Month Change
-15.50%
6-Month Change
-12.46%
Year-to-Date (YTD) Change
-7.23%
1-Year Change
-13.01%
3-Year Change
-50.28%
5-Year Change
-41.19%
All-Time (Max) Change
1994.22%

Contact Information

https://www.dexcom.com
858 200 0200
6340 Sequence Drive, San Diego, CA, 92121

Company Facts

10,200 Employees
IPO DateApr 14, 2005
CountryUS
Actively Trading

Frequently Asked Questions